Trump Orders Faster Access to Psychedelic Treatments
President Trump signed an executive order to accelerate federal access to psychedelic drug treatments, with Health Secretary RFK Jr. backing ibogaine as an alternative for depression and mental health conditions. The move challenges existing Schedule I restrictions and puts the FDA and DEA on notice to adapt clinical